Year To Quarter End Consolidated Statement Of Comprehensive Income

Astellas Pharma Inc. - Filing #7604918

Concept 2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
Year to quarter end consolidated statement of comprehensive income
Statement of comprehensive income
Profit (loss)
225,095,000,000 JPY
JPY
JPY
JPY
225,095,000,000 JPY
225,095,000,000 JPY
JPY
JPY
225,095,000,000 JPY
JPY
JPY
JPY
JPY
JPY
193,055,000,000 JPY
JPY
JPY
JPY
JPY
JPY
193,055,000,000 JPY
193,055,000,000 JPY
JPY
193,055,000,000 JPY
JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.